David Chin

Biography

 David has worked in biopharmaceuticals for nearly 20 years with significant experience in recombinant protein expression, in both microbial and mammalian cell systems, and monoclonal antibody discovery and engineering.  On completion of his PhD at the University of New South Wales, Australia, he was awarded a research fellowship by the Australian Research Council (ARC) through which he researched various biopharmaceuticals in the fields of oncology and inflammation. With further training in business administration, David has taken up several senior and managing positions. Prior to joining Biosceptre David was operation manager at National Biologics Facility (NBF) at the Australian Institute for Bioengineering and Nanotechnology, University of Queensland, in the area of recombinant protein production, cell line generation and protein characterisation. In this post David managed over 20 scientific staff controlling a budget of over $A30 million, established over 30 collaborations between the biotech industry and academia and accomplished over 300 commercial and research projects at AIBN.  David was also appointed as Chief Operating Officer at Stem Cell Limited, a spin-off from University of Queensland and Monash University.

Research Interest

 Research interest on Business Development